Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.38 |
| ▸ | MEN1 | O00255 | 4/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.38 |
| ▸ | GAA | P10253 | 2/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.36 |
| ▸ | MAPT | P10636 | 6/20 | 0.34 |
| ▸ | BCHE | P06276 | 1/20 | 0.34 |
| ▸ | ACHE | P22303 | 1/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 3/20 | 0.32 |
| ▸ | RAB9A | P51151 | 2/20 | 0.32 |
| ▸ | NPC1 | O15118 | 1/20 | 0.32 |
| ▸ | THRA | P10827 | 1/20 | 0.32 |
| ▸ | THRB | P10828 | 1/20 | 0.32 |
| ▸ | VDR | P11473 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8307242 | 0.81 | SMN1; SMN2 (0.46) | ALDH1A1MEN1KMT2AMAPK1L3MBTL1 | |
| SCHEMBL8300946 | 0.75 | ALDH1A1 (0.47) | ALDH1A1MEN1KMT2AMAPK1L3MBTL1 | |
| SCHEMBL2029141 | 0.75 | ALDH1A1 (0.38) | ALDH1A1MEN1KMT2AMAPK1L3MBTL1 | |
| SCHEMBL31335570 | 0.75 | ALDH1A1 (0.38) | ALDH1A1MEN1KMT2AMAPK1L3MBTL1 | |
| SCHEMBL8302742 | 0.67 | ALDH1A1 (0.50) | ALDH1A1MEN1KMT2AMAPK1L3MBTL1 | |
| SCHEMBL8306053 | 0.65 | ALDH1A1 (0.48) | ALDH1A1MEN1KMT2AMAPK1L3MBTL1 | |
| SCHEMBL8306989 | 0.64 | ALDH1A1 (0.44) | ALDH1A1MEN1KMT2AMAPK1L3MBTL1 | |
| SCHEMBL8304839 | 0.63 | ALDH1A1 (0.46) | ALDH1A1MEN1KMT2AMAPK1L3MBTL1 | |
| SCHEMBL8301531 | 0.63 | ALDH1A1 (0.46) | ALDH1A1MEN1KMT2AMAPK1L3MBTL1 | |
| SCHEMBL28251197 | 0.63 | KMT2A (0.46) | ALDH1A1MEN1KMT2AMAPK1L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-1998056779-A1 | 4-SULFINYL BENZAMIDES AS CALCITONIN GENE-RELATED PEPTIDE RECEPTOR ANTAGONISTS | SMITHKLINE BEECHAM CORPORATION (US) | 1998-12-17 | — | — | WO | claimed |
| US-20230181693-A1 | METHODS OF TREATING INFLAMMATORY SKIN DISORDERS | NEPSONE EHF (IS) | 2023-06-15 | — | — | US | disclosed |
| US-11433119-B2 | Methods of treating inflammatory skin disorders | NEPSONE EHF (IS) | 2022-09-06 | — | — | US | disclosed |
| US-11266718-B2 | Methods of treating inflammatory skin disorders | NEPSONE EHF (IS) | 2022-03-08 | — | — | US | disclosed |
| US-20200338168-A1 | METHODS OF TREATING INFLAMMATORY SKIN DISORDERS | NEPSONE EHF (IS) | 2020-10-29 | — | — | US | disclosed |
| US-20200338170-A1 | METHODS OF TREATING INFLAMMATORY SKIN DISORDERS | NEPSONE EHF (IS) | 2020-10-29 | — | — | US | disclosed |
| US-10668132-B2 | Use of CGRP antagonist compounds for treatment of psoriasis | NEPSONE EHF (IS) | 2020-06-02 | — | — | US | disclosed |
| US-20170065681-A1 | USE OF CGRP ANTAGONIST COMPOUNDS FOR TREATMENT OF PSORIASIS | NEPSONE EHF (IS) | 2017-03-09 | — | — | US | disclosed |
| US-9585940-B2 | Use of CGRP antagonist compounds for treatment of psoriasis | BIRKIR SVEINSSON (IS) | 2017-03-07 | — | — | US | disclosed |
| US-20140220030-A1 | USE OF CGRP ANTAGONIST COMPOUNDS FOR TREATMENT OF PSORIASIS | SVEINSSON, BIRKIR (IS) | 2014-08-07 | — | — | US | disclosed |
| US-20110150890-A1 | USE OF CGRP ANTAGONIST COMPOUNDS FOR TREATMENT OF PSORIASIS | SVEINSSON BIRKIR | 2011-06-23 | — | — | US | disclosed |
| EP-1556020-B1 | USE OF CGRP ANTAGONIST COMPOUNDS FOR TREATMENT OF PSORIASIS | ACTAVIS GROUP HF (IS) | 2009-02-25 | — | — | EP | disclosed |
| EP-1556020-A2 | USE OF CGRP ANTAGONIST COMPOUNDS FOR TREATMENT OF PSORIASIS | Sveinsson, Birkir (IS) | 2005-07-27 | — | — | EP | disclosed |
| EP-1495059-A1 | LOW MOLECULAR WEIGHT COPOLYMER OF ETHYLENE AND VINYL AROMATIC MONOMER AND USES THEREOF | DOW GLOBAL TECHNOLOGIES INC. (US) | 2005-01-12 | — | — | EP | disclosed |
| WO-2004014351-A2 | USE OF CGRP ANTAGONIST COMPOUNDS FOR TREATMENT OF PSORIASIS | SVEINSSON BIRKIR (IS) | 2004-02-19 | — | — | WO | disclosed |
| WO-2003087178-A1 | LOW MOLECULAR WEIGHT COPOLYMER OF ETHYLENE AND VINYL AROMATIC MONOMER AND USES THEREOF | DOW GLOBAL TECHNOLOGIES INC. (US) | 2003-10-23 | — | — | WO | disclosed |
| WO-1998056779-A1 | 4-SULFINYL BENZAMIDES AS CALCITONIN GENE-RELATED PEPTIDE RECEPTOR ANTAGONISTS | SMITHKLINE BEECHAM CORPORATION (US) | 1998-12-17 | — | — | WO | disclosed |